slides · global inventory
Disclaimer
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,127
Current window 31,741-31,770
Pages 1,371
Rows per page 30
Component
31,741-31,770 of 41,127
31
Includes a detailed disclaimer regarding the use of non-GAAP constant currency measures.LKQ | Results Presentation Deck | 40 slides · LKQ
Conference presentation Investor relations Beat · Action1 hit
32
Includes a detailed disclaimer regarding the definition and use of Segment EBITDA as a non-GAAP financial measure.LKQ | Results Presentation Deck | 40 slides · LKQ
Conference presentation Investor relations Beat · Action1 hit
33
Includes footnotes regarding Uni-Select acquisition and Ukraine/Russia conflict impacts.LKQ | Results Presentation Deck | 40 slides · LKQ
Conference presentation Investor relations Beat · Action1 hit
34
LKQ | Results Presentation Deck | 40 slidesLKQ | Results Presentation Deck | 40 slides · LKQ
Conference presentation Investor relations Beat · Action1 hit
37
Includes a disclaimer paragraph at the bottom regarding the methodology for non-GAAP financial measures.LKQ | Results Presentation Deck | 40 slides · LKQ
Conference presentation Investor relations Beat · Action1 hit
02
LVMH | Results Presentation Deck | 29 slidesLVMH | Results Presentation Deck | 29 slides · LVMH
Conference presentation Investor relations 1 hit
29
The table includes two distinct blocks for 2023 and 2022, showing quarterly, half-year (H1), and nine-month (9M) figures.LVMH | Results Presentation Deck | 29 slides · LVMH
Conference presentation Investor relations 1 hit
03
MAIA Biotechnology | Investor Presentation Deck | 39 slidesMAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
17
Data presented in a table format with specific clinical definitions for DCR and treatment lines.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
20
The chart tracks individual patient outcomes over time, including treatment status, response type, and study exit reasons.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
02
Mainz Biomed NV | Investor Presentation Deck | 27 slidesMainz Biomed NV | Investor Presentation Deck | 27 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
13
The slide uses a horizontal timeline to contrast current (2023-2024) and future (2024-2025) clinical trial phases.Mainz Biomed NV | Investor Presentation Deck | 27 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
18
The slide uses two scatter plots to compare sensitivity vs specificity for CRC and AA, with Mainz Biomed highlighted as a top performer.Mainz Biomed NV | Investor Presentation Deck | 27 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
25
Includes income statement highlights and balance sheet data.Mainz Biomed NV | Investor Presentation Deck | 27 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
26
Mainz Biomed NV | Investor Presentation Deck | 27 slidesMainz Biomed NV | Investor Presentation Deck | 27 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
02
Mainz Biomed NV | Investor Presentation Deck | 28 slidesMainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
13
The slide uses a process flow to demonstrate the technical workflow of the diagnostic test.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations Beat · Solution1 hit
27
Mainz Biomed NV | Investor Presentation Deck | 28 slidesMainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
02
Matson | Results Presentation Deck | 10 slidesMatson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations 1 hit
04
The slide presents preliminary financial results for Matson, including income statement components and debt/cash positions.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · Financials1 hit
02
Matson | Results Presentation Deck | 18 slidesMatson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · Attention1 hit
12
Includes GAAP EPS, depreciation, and EBITDA metrics.Matson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · SatisfactionLoop · So What Cascade1 hit
18
Includes two separate tables for three-month and nine-month periods.Matson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · Action1 hit
01
MaxCyte | Investor Presentation Deck | 19 slidesMaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations 1 hit
02
MaxCyte | Investor Presentation Deck | 19 slidesMaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations 1 hit
19
MaxCyte | Investor Presentation Deck | 19 slidesMaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations Loop · Why Now1 hit
02
Nemaura Medical | Investor Presentation Deck | 19 slidesNemaura Medical | Investor Presentation Deck | 19 slides · Nemaura Medical
Pitch deck Investor relations 1 hit
02
New York Community Bancorp | Results Presentation Deck | 32 slidesNew York Community Bancorp | Results Presentation Deck | 32 slides · New York Community Bancorp
Conference presentation Investor relations Beat · Setup1 hit
03
The slide uses a three-row layout to categorize key financial metrics.New York Community Bancorp | Results Presentation Deck | 32 slides · New York Community Bancorp
Conference presentation Investor relations Beat · Setup1 hit
04
Includes non-GAAP adjustments and profitability metrics.New York Community Bancorp | Results Presentation Deck | 32 slides · New York Community Bancorp
Conference presentation Investor relations Beat · KPI OverviewLoop · Zoom In1 hit